Orally administrable heparin derivatives
    1.
    发明公开
    Orally administrable heparin derivatives 有权
    口服维生素

    公开(公告)号:EP1792621A1

    公开(公告)日:2007-06-06

    申请号:EP05111534.3

    申请日:2005-11-30

    申请人: DEBIOPHARM S.A.

    IPC分类号: A61K31/727 A61K9/00

    CPC分类号: A61K31/727

    摘要: The invention relates to pharmaceutical compositions useful for oral administration comprising N-acetylated, oversulfated heparin characterized by the following parameters: percentage of N-acetylation >50%, degree of sulfation >2.5, weight average molecular weight comprised between 1,600 and 10,000.

    摘要翻译: 本发明涉及用于口服给药的药物组合物,其包含N-乙酰化的过硫酸化肝素,其特征在于以下参数:N-乙酰化百分比> 50%,硫酸化度> 2.5,重均分子量在1600至10,000之间。